← Browse by Condition
Medical Condition
blasts 10 percent or more of bone marrow nucleated cells
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT03589729 Phase 2
Recruiting
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers
Enrollment
100 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT02115295 Phase 2
Recruiting
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Enrollment
508 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center